GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codexis Inc (LTS:0I0X) » Definitions » Shiller PE Ratio

Codexis (LTS:0I0X) Shiller PE Ratio : (As of May. 23, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Codexis Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Codexis Shiller PE Ratio Historical Data

The historical data trend for Codexis's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codexis Shiller PE Ratio Chart

Codexis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Codexis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Codexis's Shiller PE Ratio

For the Biotechnology subindustry, Codexis's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Codexis's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Codexis's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Codexis's Shiller PE Ratio falls into.



Codexis Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Codexis's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Codexis's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.16/131.7762*131.7762
=-0.160

Current CPI (Mar. 2024) = 131.7762.

Codexis Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.220 100.560 -0.288
201409 -0.120 100.428 -0.157
201412 0.010 99.070 0.013
201503 -0.140 99.621 -0.185
201506 -0.140 100.684 -0.183
201509 0.130 100.392 0.171
201512 -0.050 99.792 -0.066
201603 -0.170 100.470 -0.223
201606 0.050 101.688 0.065
201609 0.030 101.861 0.039
201612 -0.130 101.863 -0.168
201703 -0.180 102.862 -0.231
201706 -0.130 103.349 -0.166
201709 -0.210 104.136 -0.266
201712 0.020 104.011 0.025
201803 -0.100 105.290 -0.125
201806 -0.070 106.317 -0.087
201809 -0.040 106.507 -0.049
201812 -0.010 105.998 -0.012
201903 -0.090 107.251 -0.111
201906 -0.120 108.070 -0.146
201909 0.010 108.329 0.012
201912 -0.010 108.420 -0.012
202003 -0.130 108.902 -0.157
202006 -0.110 108.767 -0.133
202009 -0.100 109.815 -0.120
202012 -0.060 109.897 -0.072
202103 -0.140 111.754 -0.165
202106 -0.070 114.631 -0.080
202109 0.030 115.734 0.034
202112 -0.160 117.630 -0.179
202203 -0.130 121.301 -0.141
202206 -0.040 125.017 -0.042
202209 -0.150 125.227 -0.158
202212 -0.190 125.222 -0.200
202303 -0.340 127.348 -0.352
202306 -0.170 128.729 -0.174
202309 -0.500 129.860 -0.507
202312 -0.100 129.419 -0.102
202403 -0.160 131.776 -0.160

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Codexis  (LTS:0I0X) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Codexis Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Codexis's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Codexis (LTS:0I0X) Business Description

Traded in Other Exchanges
Address
200 Penobscot Drive, Redwood, CA, USA, 94063
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment. Geographically, it derives a majority of revenue from the APAC.

Codexis (LTS:0I0X) Headlines

No Headlines